Vaccines are in the news again – along with misinformation about their safety. We replace the common myths with truths about the safety and benefits of vaccination in this week’s Medical Minute.
As the biggest vaccination effort in U.S. history gets underway, several states may not have enough facilities in some areas to administer the COVID-19 vaccine to all residents who want it, according to a new analysis from the University of Pittsburgh School of Pharmacy and the nonprofit West Health.
Greg Whitcher, M.D., a resident in the Department of Emergency Medicine at Texas Tech University Health Sciences Center El Paso, explains how the COVID-19 vaccine works.
Key Takeaways: • Memorial Hermann is proud to be part of history in the making, as the first health systems across the country begin receiving and administering the Pfizer COVID-19 vaccine to their frontline healthcare workers • Memorial Hermann’s first vaccine was given to Robert Luckey, a nurse in the COVID ICU at Memorial Hermann-Texas Medical Center • To date, Memorial Hermann has treated more than 12,000 COVID-19 positive patients in its hospitals, more than any other health system in the Greater Houston area • The system expects to receive 16,575 doses of the Pfizer vaccine in the first allotment, more than any other health system in the Greater Houston area • It’s important that everyone continues practicing the three “W’s”: wearing a mask, watching social distance and washing hands frequently
The Association of American Cancer Institutes (AACI) commends the U.S. Food and Drug Administration (FDA) for its swift action to grant Emergency Use Authorization (EUA) to Pfizer’s COVID-19 vaccine.
The FDA granted emergency use authorization today for an innovative COVID-19 viral antigen test developed with support from NIH’s RADx Initiative.
Frontline healthcare workers at Cedars-Sinai and the broader Los Angeles community saw light at the end of the pandemic tunnel as the much-anticipated COVID-19 vaccine arrived at the academic medical center Tuesday. Downloadable video available.
With the first round of COVID-19 vaccines being deployed to states across the country, the American Society of Anesthesiologists (ASA) advises that anesthesia professionals, and other frontline health care workers, be prioritized to receive early access to the COVID-19 vaccination given their high risk of exposure to the virus in operating rooms, labor and delivery suites, procedural areas, emergency rooms and critical care units.
Vaccines that prevent infection by SARS-CoV-2, the virus that causes COVID-19, are being rolled out around the world. Below are five things about vaccine science of which you may be unaware. Additionally, here is a video about how vaccines are determined safe.
A team of scientists from The Wistar Institute, INOVIO, AstraZeneca, the Perelman School of Medicine at the University of Pennsylvania, and Indiana University has received a $37.6 million award over two years from the Defense Advanced Research Projects Agency (DARPA) and the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) for rapid preclinical development and translational studies of DNA-encoded monoclonal antibodies (DMAbs) as countermeasures for COVID-19.
Join us for a virtual press conference as Keck Medicine of USC experts discuss how the health system is handling the receipt and distribution of vaccines the day before vaccinations begin.
National efforts to develop a coronavirus disease 2019 (COVID-19) vaccine at “warp speed” will likely yield a safe and effective vaccine by early 2021. However, this important milestone is only the first step in an equally important challenge: getting a majority of the U.S. public vaccinated.
University Health Network (UHN) today gave the first COVID-19 vaccine in Canada. This landmark event signals a potential turning point in the pandemic and underlines the value of science and worldwide cooperation.
At the 2020 AACC Annual Scientific Meeting & Clinical Lab Expo, a series of late-breaking sessions will delve into the newest research on the rapidly evolving COVID-19 pandemic. Highlights of these sessions include a talk that will provide expert insight into the many coronavirus vaccines currently in development, as well as an expert presentation on coronavirus immunity and antibody testing.
The availability of COVID-19 vaccines will not necessarily result in people getting fully vaccinated, because the first vaccines require a second dose within a few weeks to get full protection. Mark Fendrick, M.D., has studied barriers to preventive health services and offers suggestions based on past research for how to ensure full vaccination.
New research by scientists at the University of Chicago suggests a person’s antibody response to influenza viruses is dramatically shaped by their pre-existing immunity, and that the quality of this response differs in individuals who are vaccinated or naturally infected. Their results highlight the importance of receiving the annual flu vaccine to induce the most protective immune response.
A new online calculator for estimating individual and community-level risk of dying from COVID-19 has been developed by researchers at the Johns Hopkins Bloomberg School of Public Health.
GreenMedInfo, an alternative health website that has published articles claiming vaccines cause autism, published an article on December 6th warning about the adverse side effects of the coronavirus vaccines, including death. We rate this article as mostly false and misleading.
As the U.S. authorizes distribution of the COVID vaccines from Pfizer and Moderna, here’s what you need to know about the vaccines — how they work, the doses required, their effectiveness and more.
Investigators at Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School recently identified a new method for safe and effective delivery of medicines to the lungs that can be used for multiple clinical applications, potentially including aerosol vaccination.
Researchers from the National University of Singapore have utilised a ground-breaking AI platform to find an optimal combination of available therapies against COVID-19. The research team identified the drug combination from over 530,000 possibilities within two weeks, cutting down the number of tests typically needed by hundreds of thousands.
**All experts also available for interviews prior to event and EUA Advisory Committee Meetings** **B-roll and lab photos of Drs. Weissman and Wherry shot this month, headshots of the others, and photos from Penn’s Moderna vaccine trial participants getting vaccinated, are available for use**
A Rutgers philosopher examines the ethical questions around human challenge trials for COVID-19 vaccines
UC Davis Health will launch a COVID-19 clinical trial with Novavax to test a new coronavirus vaccine. This vaccine has an important advantage: liquid state storage that allows for distribution using standard vaccine channels, unlike the Pfizer and Moderna vaccines that must be stored at subzero temperature.
In this free STS webinar, Next Steps in Eradicating COVID-19: Emerging Treatments and Vaccines, STS President Dr. Joseph Dearani will talk with infectious disease experts from the White House Coronavirus Task Force and Mayo Clinic about promising new treatments and preventive measures.
A vaccine that induces immune responses to a wide spectrum of influenza virus strains and subtypes has produced strong and durable results in early-stage clinical trials in humans, Mount Sinai researchers have found.
The American Association of Nurse Anesthetists (AANA) commends the U.S. Centers for Disease Control and Prevention’s (CDC's) team of advisors on prioritizing frontline healthcare personnel and residents of long-term facilities for the first phase of the COVID-19 vaccine distribution.
Chemist Meredith Jackrel studies protein misfolding and how it leads to disease. She is collaborating engineers to develop amyloid-inspired vaccine technologies specifically tailored for seniors. The approach could be relevant to COVID-19 as the elderly are particularly susceptible to its severe complications.
“Following the swi. review— and subsequent guidance— by the NIH and theCDC of Ivermectin, we expect that Ivermectin’s widespread, immediate use willallow for a rapid and safe re-opening of businesses and schools across the nation—and quickly reduce the strain on overwhelmed ICUs.” —FLCCC Alliance
In a new paper in the journal Nature, BIDMC researchers shed light on the role of antibodies and immune cells in protection against SARS-CoV-2, the virus that causes COVID-19, in rhesus macaques.
Nearly half of all patients served by community health centers (CHCs) qualify for phase one COVID-19 immunizations under priority guidelines established by the Centers for Disease Control and Prevention, according to a new analysis produced by researchers at the Geiger Gibson/RCHN Community Health Foundation Research Collaborative.
As coronavirus cases rage throughout the United States—killing more than a quarter million in the U.S.—news of the effectiveness of vaccine candidates provides hope.
The SARS-CoV-2 pandemic continues to have a considerable impact on the provision of appropriate care to people with psoriasis.
Differences in the immune systems and better blood vessel health were among the factors protecting children from severe COVID-19, according to a new review.
Associate Professor Tinglong Dai of the Johns Hopkins Carey Business School, an expert in health care industry operations management and business analytics, examines the daunting process of administering a COVID-19 vaccine globally.
Millions around the world have waited for news about a COVID-19 vaccine, regarding it as the beginning of the end for the global pandemic and a herald for the eventual return to “normal life.” Recent announcements from pharmaceutical companies Pfizer and Moderna that their respective late-stage vaccine trials have shown a 90% or better effectiveness rate have received international applause, excitement furthered with estimates that doses could be ready as early as December.
ADE has not been shown to occur in individuals that received COVID-19 vaccines to date.
More than 90 percent of human papillomavirus (HPV)-related cancers could be prevented by widespread uptake of the HPV vaccine. Yet, vaccine use in the United States falls short of public health goals.
The recent serious outbreak of Covid19 has affected (November 13, 2020) 53,796,098 people worldwide, resulting in 37,555,669 recovered, 1,310,250 deaths (Figure 1), and a large number of open cases.
Irvine, Calif., Dec. 1, 2020 — The coming of winter means cooler temperatures, shorter days and flu shots. While no one looks forward to a vaccination, a study led by the University of California, Irvine, has found that either a sincere smile or a grimace can reduce the pain of a needle injection by as much as 40 percent. A genuine, or Duchenne, smile – one that elevates the corners of the mouth and creates crow’s feet around the eyes – can also significantly blunt the stressful, needle-related physiological response by lowering the heart rate.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right